# Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery

Study · id `cardio:ct-nct06675500` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06675500](<https://clinicaltrials.gov/study/NCT06675500>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06675500

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

## Technical summary

Registry record NCT06675500. Randomized; double masking; primary purpose prevention. Start 2024-11-01 (actual); primary completion 2025-04-15 (actual). Results posted on 2025-08-17.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 130 participants (enrolled count; ClinicalTrials.gov record NCT06675500, source copy `cardio:ctgov-nct06675500-2025-08-17`, retrieved 2026-10-26)
- Started: 2024-11-01 (actual) (ClinicalTrials.gov record NCT06675500, source copy `cardio:ctgov-nct06675500-2025-08-17`, retrieved 2026-10-26)
- Primary completion: 2025-04-15 (actual) (ClinicalTrials.gov record NCT06675500, source copy `cardio:ctgov-nct06675500-2025-08-17`, retrieved 2026-10-26)
- Completion: 2025-04-30 (actual) (ClinicalTrials.gov record NCT06675500, source copy `cardio:ctgov-nct06675500-2025-08-17`, retrieved 2026-10-26)
- Results first posted: 2025-08-17 (ClinicalTrials.gov record NCT06675500, source copy `cardio:ctgov-nct06675500-2025-08-17`, retrieved 2026-10-26)
- Countries: Egypt (ClinicalTrials.gov record NCT06675500, source copy `cardio:ctgov-nct06675500-2025-08-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06675500-2025-08-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery
- Acronym: Magnesium AF
- Condition: Atrial Fibrillation (AF)
- Condition: Magnesium Sulfate
- Condition: Post Cardiac Surgery Patients
- Intervention (Drug): Magnesium sulphate
- Intervention (Drug): Placebo
- Lead sponsor: Ain Shams University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Ain Shams University (`cardio:org-ain-shams-university`)

## Provenance

Content hash: a5856f9488506b502ca600226ea1d73bdca4438483d4f62e00b39eff04404039
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
